RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: alcohol use disorder
Accession: DOID:1574
browse the term
Definition: A substance abuse that involves the recurring use of alcoholic beverages despite negative consequences. (DO)
Synonyms: exact_synonym: alcohol abuse; chronic alcoholic intoxication; ethanol abuse
related_synonym: Beta-glycopyranoside tasting
primary_id: MESH:D000437
xref: ICD10CM:F10.1 ; ICD9CM:305.0 ; NCI:C20701
For additional species annotation, visit the
Alliance of Genome Resources .
G
Acads
acyl-CoA dehydrogenase short chain
susceptibility
ISO
DNA:SNP:: (rs1799958) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr12:47,154,259...47,163,580
Ensembl chr12:41,493,626...41,502,898
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16404797
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:226,797,303...226,808,892
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
IMP
RGD
PMID:8462548
RGD:5129091
NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:226,947,466...226,987,591
G
Ager
advanced glycosylation end product-specific receptor
treatment onset
IEP ISO
mRNA, protein:increased expression:orbitofrontal cortex, neurons protein:increased expression:frontal cortex neuron
RGD
PMID:33716687 PMID:23867237 PMID:23867237 PMID:23867237 PMID:32664441
RGD:597538457 , RGD:597538460 , RGD:597538460 , RGD:597538460 , RGD:597805903
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16404797 PMID:17590986 PMID:10780266
RGD:734551
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Ankk1
ankyrin repeat and kinase domain containing 1
severity
ISO
DNA:polymorphism: :rs1800497(human) DNA:SNP,haplotype: :rs11604671, rs4938015 (human)
RGD
PMID:32889058 PMID:21936764
RGD:401940151 , RGD:401959296
NCBI chr 8:49,779,862...49,788,024
Ensembl chr 8:49,779,862...49,788,024
G
Apc2
APC regulator of WNT signaling pathway 2
ISO
DNA, mRNA, protein:hypermethylation, decreased expression:brain
RGD
PMID:31239533
RGD:407987270
NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:9,392,336...9,414,310
G
App
amyloid beta precursor protein
IEP
protein:increased expression:liver protein:increased expression:cerebellum, hippocampus, striatum
RGD
PMID:36187787 PMID:21345314
RGD:597830170 , RGD:597830177
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Arc
activity-regulated cytoskeleton-associated protein
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Avp
arginine vasopressin
IEP
mRNA:altered expression:central amygdaloid nucleus, medial amygdaloid nucleus, medial zone of hypothalamus protein:decreased expression:suprachiasmatic nucleus
RGD
PMID:21575018 PMID:11709626
RGD:408364978 , RGD:596933084
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bace1
beta-secretase 1
IEP
protein:increased expression:cerebellum, hippocampus, striatum
RGD
PMID:21345314
RGD:597830177
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:46,142,116...46,165,876
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP ISO
protein:decreased expression:plasma protein:decreased expression:plasma (human) mRNA,protein:decreased expression:hippocampus, plasma (rat) protein:altered expression:brain protein:decreased expression:cerebellum, hippocampus mRNA, protein:altered expression:brain
RGD
PMID:32135570 PMID:30277635 PMID:30277635 PMID:15307153 PMID:19100286 PMID:33919862 PMID:32330588 More...
RGD:35673317 , RGD:401938665 , RGD:401938665 , RGD:401965482 , RGD:401976492 , RGD:596933362 , RGD:596936412
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Calb1
calbindin 1
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:29,375,642...29,402,431
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
ISO
mRNA:increased expression:prefrontal cortex
RGD
PMID:28714806
RGD:18337277
NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:150,673,507...150,676,600
G
Camk4
calcium/calmodulin-dependent protein kinase IV
IEP
protein:decreased expression:brain, cingulate gyrus
RGD
PMID:11181917
RGD:401959326
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Cartpt
CART prepropeptide
susceptibility
ISO
DNA:SNPs: : rs11575893,rs16871471
RGD
PMID:20362026
RGD:597805891
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Cast
calpastatin
IEP
protein:increased expression:gastrocnemius (rat)
RGD
PMID:28800153
RGD:405100967
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
treatment
IEP
associated with diabetes;protein:decreased activity:liver, kidney (rat) associated with cognitive disorder; protein:altered activity:hippocampus (rat) associated with cardiomyopathy associated with diabetes; protein:decreased activity;testis, epididymis (rat)
RGD
PMID:22596042 PMID:21713042 PMID:27367870 PMID:7195942 PMID:25541261
RGD:405255659 , RGD:405255660 , RGD:405255662 , RGD:405255663 , RGD:405255664
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cckar
cholecystokinin A receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9922984
NCBI chr14:61,505,270...61,513,618
Ensembl chr14:57,292,397...57,300,747
G
Cdk20
cyclin-dependent kinase 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr17:706,863...717,828
Ensembl chr17:701,124...707,826
G
Chrm5
cholinergic receptor, muscarinic 5
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:33942300
RGD:597957923
NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:99,284,846...99,337,252
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:55,369,794...55,398,146
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
severity
ISO
DNA:haplotypes: :
RGD
PMID:19698703
RGD:405849410
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:64,697,741...64,704,441
G
Clock
clock circadian regulator
susceptibility
ISO
DNA:SNP:: (rs2412648) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400
G
Cnr1
cannabinoid receptor 1
sexual_dimorphism
IEP
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:: DNA:polymorphism: :rs4680(human)
CTD RGD
PMID:10395222 PMID:10395222 PMID:32889058
RGD:401940114 , RGD:401940151
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
sexual_dimorphism
IEP IDA
mRNA, protein:decreased expression:amygdala protein:altered expression, altered phosphorylation:liver, nucleus protein:increased phosphorylation:liver
RGD
PMID:29991681 PMID:22269225 PMID:31262967
RGD:401938626 , RGD:401959317 , RGD:401959334
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crebbp
CREB binding protein
IEP
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Crh
corticotropin releasing hormone
IEP
mRNA:increased expression:central amygdaloid nucleus (rat)
RGD
PMID:20060104
RGD:5508173
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:102,143,055...102,144,919
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
RGD
PMID:11988580
RGD:734822
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,040,203...89,083,481
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma, extracellular exosome
CTD RGD
PMID:20843640 PMID:29404485 PMID:29404485 PMID:23819932
RGD:14700911 , RGD:14700911 , RGD:14700915
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Dbh
dopamine beta-hydroxylase
no_association
ISO
DNA:polymorphism:5' utr:g.-1021C>T (human) DNA:polymorphism:cds:g.444G>A (human)
RGD
PMID:16133787 PMID:16252068
RGD:1625572 , RGD:1625571
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248
G
Dbi
diazepam binding inhibitor
ISO
mRNA,protein:increased expression:cerebral cortex (mouse)
RGD
PMID:9526063
RGD:408346747
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Dcx
doublecortin
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:107,430,767...107,507,476
G
Dlg4
discs large MAGUK scaffold protein 4
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:mRNA,protein:decreased expression:brain (mouse)
RGD
PMID:30016666
RGD:401959614
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:54,739,470...54,767,153
G
Drd2
dopamine receptor D2
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd4
dopamine receptor D4
treatment susceptibility
ISO
DNA:repeats:exon: associated with peer pressure;DNA:repeats:exon:
RGD
PMID:25640830 PMID:26307243
RGD:11064848 , RGD:401959598
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Ep300
E1A binding protein p300
IEP
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
IEP
RGD
PMID:23095216
RGD:10045658
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
G
Fgf2
fibroblast growth factor 2
IMP
RGD
PMID:28821667 PMID:31375540
RGD:405855870 , RGD:405855874
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fmr1
fragile X messenger ribonucleoprotein 1
IEP
mRNA:increased expression:cerebellum
RGD
PMID:34453331
RGD:401938639
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:147,240,301...147,278,050
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP ISO IDA
protein:increased expression:brain protein:increased expression:parvocellular oculomotor nucleus
RGD
PMID:14741756 PMID:11164784 PMID:29210146
RGD:405255650 , RGD:405255652 , RGD:405295495
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
treatment
IEP ISO
protein:increased expression:brain (mouse) protein:increased expression:dorsal striatum (mouse)
RGD
PMID:22792289 PMID:9835277 PMID:27380261
RGD:401851082 , RGD:401901184 , RGD:401901287
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Fshb
follicle stimulating hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
susceptibility
ISO
DNA:SNP:intron: (rs2900512) (human)
RGD
PMID:28118741
RGD:401940105
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:60,947,526...61,288,104
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
susceptibility
ISO
DNA:SNPs:multiple: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22253714 PMID:15024690
RGD:6480257
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,097,279...37,228,944
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
susceptibility
ISO
DNA:CA repeats: :(human)
RGD
PMID:9858031
RGD:405866342
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:108,296,124...108,698,961
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gata4
GATA binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20585342
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:37,459,601...37,505,636
G
Gdnf
glial cell derived neurotrophic factor
treatment
ISO IDA IEP
protein:increased expression:serum DNA:hypomethylation:nucleus accumbens associated with Tobacco Use Disorder;mRNA:decreased expression:ventral tegmental area
RGD
PMID:25623403 PMID:31710958 PMID:22238721 PMID:28559549
RGD:401965480 , RGD:405820205 , RGD:405849387 , RGD:405850249
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12747453
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Ghsr
growth hormone secretagogue receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23977009
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:110,268,489...110,271,865
G
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:96,892,148...97,483,612
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ISO IEP
protein:increased phosphorylation:lumbar spinal cord (mouse) protein:increased expression:nucleus accumbens (rat) protein:increased expression:nucleus accumbens (mouse) protein:increased expression, increased phosphorylation:cingulate cortex (rat) protein:decreased expression:neocortex (rat)
RGD
PMID:28585190 PMID:21041654 PMID:21041654 PMID:34280506 PMID:12036520
RGD:405100727 , RGD:405650686 , RGD:405650686 , RGD:405818275 , RGD:405820203
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
IEP
protein:decreased expression:neocortex (rat) protein:increased expression:ventral CA1 field of hippocampus (rat)
RGD
PMID:12036520 PMID:30481568
RGD:405820203 , RGD:596933081
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
RGD
PMID:14573320
RGD:1642372
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO IEP
RGD
PMID:14573320 PMID:16911840 PMID:32664441
RGD:1642372 , RGD:1642200 , RGD:597805903
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Grm5
glutamate metabotropic receptor 5
treatment
IEP
RGD
PMID:32664441
RGD:597805903
NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:141,312,368...141,882,274
G
Gstp1
glutathione S-transferase pi 1
ISO
DNA:SNP:: rs1695(human)
RGD
PMID:31886888
RGD:597621684
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hdac2
histone deacetylase 2
IMP
RGD
PMID:23485013
RGD:9590265
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hmgb1
high mobility group box 1
onset treatment
ISO IEP
protein:increased expression:orbitofrontal cortex protein:increased expression:frontal cortex neuron
RGD
PMID:23867237 PMID:23867237 PMID:32664441
RGD:597538460 , RGD:597538460 , RGD:597805903
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Htr1a
5-hydroxytryptamine receptor 1A
treatment
IMP
RGD
PMID:9631953
RGD:401900760
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
sexual_dimorphism no_association onset
ISO
associated with attention deficit hyperactivity disorder;DNA:SNP: :rs11568817(human) DNA:SNPs: :multiples (human) DNA:SNP: :rs13212041 (human)
RGD
PMID:28923721 PMID:11496363 PMID:30774345
RGD:405650695 , RGD:405818272 , RGD:405847403
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
treatment
IEP IMP
mRNA, protein:decreased expression:cerebral cortex, liver protein:increased expression:dorsal raphe, nucleus accumbens
RGD
PMID:20501057 PMID:9347075 PMID:9347073 PMID:9631953
RGD:401900301 , RGD:401900740 , RGD:401900742 , RGD:401900760
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
treatment
IDA
RGD
PMID:24041931
RGD:401900761
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:110,641,153...110,870,287
G
Htr3a
5-hydroxytryptamine receptor 3A
ISO
DNA:hypermethylation, hypomethylation:promoter: (mouse)
RGD
PMID:22834954
RGD:404976877
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Htr3b
5-hydroxytryptamine receptor 3B
susceptibility
ISO
DNA:SNP:cds:rs1176744(human)
RGD
PMID:20838391
RGD:6480660
NCBI chr 8:58,175,785...58,204,939
Ensembl chr 8:49,279,173...49,308,444
G
Htr7
5-hydroxytryptamine receptor 7
ISO
DNA:SNP:intron: (rs7916403) (human)
RGD
PMID:21184583
RGD:150429835
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:233,636,452...233,760,626
G
Igf2
insulin-like growth factor 2
ISO
protein:decreased expression:plasma (human)
RGD
PMID:30277635
RGD:401938665
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Il10
interleukin 10
IEP
mRNA:increased expression:liver
RGD
PMID:22269225
RGD:401959317
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il6
interleukin 6
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:26208141
RGD:11342768
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
ISO
DNA:SNP:promoter:rs2836016 (human)
RGD
PMID:21307845
RGD:6483053
NCBI chr11:47,531,312...47,778,348
Ensembl chr11:34,061,708...34,308,758
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
IEP
protein:decreased expression:ventral CA1 field of hippocampus (rat)
RGD
PMID:30481568
RGD:596933081
NCBI chr18:40,004,693...40,445,043
Ensembl chr18:37,817,957...38,258,347
G
Lhb
luteinizing hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lrp1
LDL receptor related protein 1
IEP
protein:decreased expression:liver
RGD
PMID:36187787
RGD:597830170
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910
G
Maoa
monoamine oxidase A
susceptibility
ISO
RGD
PMID:15900229
RGD:1600720
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:6,030,795...6,099,593
G
Mapk1
mitogen activated protein kinase 1
IEP
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
ISO
protein:increased expression, increased phosphorylation:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
IEP
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
IDA
RGD
PMID:31262967
RGD:401959334
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mb
myoglobin
ISO
protein:decreased expression:serum
RGD
PMID:3766421
RGD:458925288
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mcm5
minichromosome maintenance complex component 5
IEP
RGD
PMID:23095216
RGD:10045658
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,483,066...13,504,389
G
Mir191
microRNA 191
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr 8:118,142,627...118,142,717
G
Mir195
microRNA 195
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:54,951,838...54,951,924
G
Mir206
microRNA 206
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr 9:30,590,697...30,590,780
Ensembl chr 9:23,094,249...23,094,332
G
Mir30a
microRNA 30a
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:25,737,600...25,737,670
G
Mki67
marker of proliferation Ki-67
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mmp2
matrix metallopeptidase 2
IEP
RGD
PMID:24966898
RGD:13207311
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IEP
RGD
PMID:24966898
RGD:13207311
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Ncam1
neural cell adhesion molecule 1
treatment sexual_dimorphism
IEP
mRNA:decreased expression:hippocampus (rat) associated with chronic stress in female rats
RGD
PMID:30277635 PMID:16207289 PMID:27894930
RGD:401938665 , RGD:401959613 , RGD:401959751
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Ncstn
nicastrin
IEP
protein:increased expression:striatum
RGD
PMID:21345314
RGD:597830177
NCBI chr13:87,062,827...87,078,839
Ensembl chr13:84,530,440...84,546,454
G
Ngf
nerve growth factor
ISO IEP
protein:increased expression:serum protein:decreased expression:brain protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:25623403 PMID:15307153 PMID:19100286
RGD:401965480 , RGD:401965482 , RGD:401976492
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Npy
neuropeptide Y
IAGP ISO
DNA:deletion:intron:g.4666_4674del (rat) DNA:missense mutation: :p.L7P (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17572454 PMID:15749341 PMID:12215082
RGD:1357412 , RGD:10430830
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Npy2r
neuropeptide Y receptor Y2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18828811
NCBI chr 2:170,200,027...170,210,286
Ensembl chr 2:167,903,879...167,905,024
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IDA IMP IEP
protein:decreased expression, decreased DNA binding:brain mRNA, protein:decreased expression:placenta
RGD
PMID:11961084 PMID:33920737 PMID:31756338 PMID:21143252
RGD:408345232 , RGD:408345239 , RGD:408345241 , RGD:408345244
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
treatment sexual_dimorphism
IMP
RGD
PMID:29437012 PMID:33007359 PMID:30171933
RGD:401965466 , RGD:401966865 , RGD:401976281
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Nrg1
neuregulin 1
sexual_dimorphism
ISO
in female, associated with stressful life event;DNA:SNP: :rs6994992(human)
RGD
PMID:27353026
RGD:405100235
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Ntf3
neurotrophin 3
ISO IEP
protein:decreased expression:plasma (human) mRNA,protein:decreased expression:hippocampus, plasma (rat) protein:increased expression:brain
RGD
PMID:30277635 PMID:30277635 PMID:15307153
RGD:401938665 , RGD:401938665 , RGD:401965482
NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:158,914,957...158,984,596
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO IEP IDA
associated with Prenatal Exposure Delayed Effects and anxiety disorder:protein:decreased acetylation:brain
RGD
PMID:30016666 PMID:8840027 PMID:32206827 PMID:33919862
RGD:401959614 , RGD:401965407 , RGD:596933095 , RGD:596933362
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprd1
opioid receptor, delta 1
IEP IMP ISO
associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNPs, haplotype:intron 1:multiple (human)
RGD
PMID:28511993 PMID:7501658 PMID:24533225
RGD:401976432 , RGD:401976439 , RGD:402525443
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
severity no_association susceptibility
ISO IEP
DNA:SNP, haplotype: :rs6473797 (human) DNA:SNP: :rs997917 (human) DNA:SNP: :rs6473797 (human) associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat)
RGD
PMID:31004399 PMID:37177778 PMID:37177778 PMID:28511993
RGD:401831037 , RGD:401850581 , RGD:401850581 , RGD:401976432
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprl1
opioid related nociceptin receptor 1
IMP
RGD
PMID:11814626
RGD:9835016
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
no_association treatment
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs510769 DNA:missense mutations, SNP:exon, intron:p.A6V, p.S147C, p.N40D (118A>G) (rs 1799971), IVS2+691G>C (human) DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human)
CTD RGD
PMID:12815747 PMID:26042510 PMID:9399694 PMID:32772383
RGD:401827930 , RGD:401827934 , RGD:401827947
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Oxt
oxytocin/neurophysin I prepropeptide
disease_progression
ISO
mRNA:increased expression:prefrontal cortex, brain (human)
RGD
PMID:28787642
RGD:597621697
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:117,782,650...117,783,490
G
Oxtr
oxytocin receptor
sexual_dimorphism
ISO
DNA:SNP:intron: (rs53576) (human) DNA:hypomethylation
RGD
PMID:27716573 PMID:35146961
RGD:597538589 , RGD:597538605
NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:145,599,561...145,614,674
G
Pde4b
phosphodiesterase 4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pdyn
prodynorphin
susceptibility no_association
ISO IEP
CTD Direct Evidence: marker/mechanism associated with cocaine dependence;DNA, mRNA:SNPs, haplotype:3' utr:rs910080, rs910079, rs2235749 (human) DNA, mRNA:SNP, decreased expression:promoter, dorsolateral prefrontal cortex:rs1997794 (human) DNA:SNP: :rs2281285 (human) DNA:SNPs: :rs2281285, rs2225749, rs910080 (human) mRNA, protein:decreased expression:hippocampus, granule cell
CTD RGD
PMID:17559549 PMID:18923396 PMID:18923396 PMID:29925858 PMID:36099111 PMID:37177778 PMID:1589146 More...
RGD:401850550 , RGD:401850559 , RGD:401850566 , RGD:401850581 , RGD:401851059
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
IEP
mRNA:increased expression:frontal lobe:
RGD
PMID:22703995
RGD:10003152
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:17,183,806...17,189,129
G
Per1
period circadian regulator 1
IEP
mRNA:altered expression: arcuate nucleus of hypothalamus
RGD
PMID:15009656
RGD:407572515
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
IEP
mRNA:altered expression: arcuate nucleus of hypothalamus, suprachiasmatic nucleus
RGD
PMID:15009656
RGD:407572515
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Per3
period circadian regulator 3
IEP
mRNA:altered expression:suprachiasmatic nucleus
RGD
PMID:15009656
RGD:407572515
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:161,459,533...161,495,607
G
Pomc
proopiomelanocortin
sexual_dimorphism
IEP ISO
protein:decreased expression:brain (rat) mRNA:increased expression: hypothalamus, pituitary gland, shell of nucleus accumbens DNA, mRNA:deletion, decreased expression:enhancer, hypothalamus mRNA, protein:increased expression:arcuate nucleus, hypothalamus, septum protein:increased expression:plasma associated with Prenatal Exposure Delayed Effects;mRNA:altered expression:adenohypophysis mRNA:altered expression: arcuate nucleus of hypothalamus
RGD
PMID:18162070 PMID:22724395 PMID:31339663 PMID:7925590 PMID:19912941 PMID:19912941 PMID:15009656 More...
RGD:401976284 , RGD:405878072 , RGD:407550221 , RGD:407571692 , RGD:407572513 , RGD:407572513 , RGD:407572515
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Rbfox1
RNA binding fox-1 homolog 1
sexual_dimorphism
ISO
DNA:SNPs:intron 1, 3: (rs8062784, rs12921846) (human)
RGD
PMID:33329073
RGD:597830062
NCBI chr10:8,658,809...10,754,648
Ensembl chr10:8,152,198...9,686,659
G
Rest
RE1-silencing transcription factor
ISO
protein:increased expression:basal forebrain
RGD
PMID:37402853
RGD:597538603
NCBI chr14:31,213,415...31,233,451
Ensembl chr14:30,862,553...30,894,354
G
Rpl18a
ribosomal protein L18A
IEP
mRNA:decreased expression:parietal cortex
RGD
PMID:11244494
RGD:11038708
NCBI chr16:18,542,555...18,544,578
Ensembl chr16:18,542,566...18,545,546 Ensembl chr 1:18,542,566...18,545,546
G
Sell
selectin L
ISO
protein:decreased expression:Tcell
RGD
PMID:7573774
RGD:597015763
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Shbg
sex hormone binding globulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,332,941...54,351,057
G
Slc1a2
solute carrier family 1 member 2
treatment
IEP
RGD
PMID:32664441
RGD:597805903
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
susceptibility
ISO
protein:decreased activity: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15520362 PMID:17000009 PMID:20838391
RGD:6480660
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18055133
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
Sod1
superoxide dismutase 1
IEP
associated with diabetes; protein:decreased activity;testis, epididymis (rat)
RGD
PMID:25541261
RGD:405255664
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sox2
SRY-box transcription factor 2
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
G
Spi1
Spi-1 proto-oncogene
treatment
IEP IDA
protein:decreased expression:alveolar macrophage
RGD
PMID:16272341 PMID:21447000
RGD:9586723 , RGD:9586725
NCBI chr 3:97,529,509...97,548,204
Ensembl chr 3:77,073,012...77,092,393
G
Spn
sialophorin
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr 1:191,177,449...191,190,115
Ensembl chr 1:181,746,429...181,759,628
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
severity
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:17697868
RGD:10043133
NCBI chr11:91,031,481...91,158,111
Ensembl chr11:77,526,837...77,653,310
G
Syp
synaptophysin
sexual_dimorphism
IEP
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19204064
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:114,920,844...115,089,733
G
Tacr3
tachykinin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422838
NCBI chr 2:225,940,497...226,037,756
Ensembl chr 2:223,266,536...223,363,791
G
Tas2r118
taste receptor, type 2, member 118
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16385453 PMID:17250611
NCBI chr 4:52,449,208...52,450,107
Ensembl chr 4:52,449,208...52,450,107
G
Tas2r138
taste receptor, type 2, member 138
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17250611
NCBI chr 4:69,428,344...69,429,339
Ensembl chr 4:69,428,344...69,429,339
G
Tbx19
T-box transcription factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr13:79,983,935...80,016,219
Ensembl chr13:77,450,849...77,504,163
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11000917 PMID:21792595
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Timeless
timeless circadian regulator
susceptibility
ISO
DNA:SNP:: (rs2291738) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 7:1,239,388...1,263,344
Ensembl chr 7:654,822...678,738
G
Tlr2
toll-like receptor 2
IEP ISO
protein:decreased expression:alveolar macrophage mRNA:increased expression:respiratory system fluid/secretion protein:decreased expression:blood, monocyte mRNA:increased expression:liver mRNA:increased expression:orbitofrontal cortex
RGD
PMID:36281822 PMID:26208141 PMID:27256567 PMID:30756376 PMID:34415075
RGD:597538461 , RGD:11342768 , RGD:597538485 , RGD:597538493 , RGD:597538499
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
onset
ISO IEP
mRNA:decreased expression:respiratory system fluid/secretion protein:decreased expression:blood, monocyte protein:increased expression:liver mRNA:increased expression:liver mRNA:increased expression:orbitofrontal cortex protein:increased expression:orbitofrontal cortex protein:increased expression:frontal cortex neuron
RGD
PMID:26208141 PMID:27256567 PMID:21276439 PMID:30756376 PMID:34415075 PMID:23867237 PMID:23867237 More...
RGD:11342768 , RGD:597538485 , RGD:150540306 , RGD:597538493 , RGD:597538499 , RGD:597538460 , RGD:597538460
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tlr5
toll-like receptor 5
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr13:97,166,430...97,190,642
Ensembl chr13:94,634,801...94,657,738
G
Tlr6
toll-like receptor 6
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,362,164...43,375,685
G
Tlr7
toll-like receptor 7
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr X:30,644,324...30,670,796
Ensembl chr X:27,027,425...27,054,754
G
Tlr8
toll-like receptor 8
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr X:30,708,714...30,733,104
Ensembl chr X:27,091,778...27,116,549
G
Tlr9
toll-like receptor 9
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
treatment
IEP
RGD
PMID:32664441
RGD:597805903
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tph1
tryptophan hydroxylase 1
ISO
RGD
PMID:15654285
RGD:1580464
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:97,157,409...97,178,344
G
Tph2
tryptophan hydroxylase 2
ISO IEP
mRNA, protein:increase3d expression:dorsal raphe nucleus, median raphe nucleus associated with temporal lobe epilepsy;DNA:SNP: :rs17110747 protein:decreased expression, increased activity:raphe nuclei protein:decreased expression:hippocampus protein:decreased expression:midbrain
RGD
PMID:24942188 PMID:24491795 PMID:32330588 PMID:26747301 PMID:27647531
RGD:597621679 , RGD:597621680 , RGD:596936412 , RGD:597805906 , RGD:597830173
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Vip
vasoactive intestinal peptide
susceptibility
ISO
DNA:SNPs, haplotype:: (rs3823082,rs688136) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:42,065,120...42,073,216
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all